Literature DB >> 12132141

[Delirium during withdrawal of venlafaxine].

M S van Noorden1, A C M Vergouwen, G F Koerselman.   

Abstract

A 35-year-old man with anxiety and depression who was treated with venlafaxine, 300 mg a day, developed severe withdrawal symptoms in the form of a delirium during gradual tapering of the dosage. The symptoms resolved when the dosage was kept constant and did not recur when the dosage was reduced more gradually. Withdrawal symptoms are common during discontinuation of antidepressants, particularly after prolonged use of agents with a short half-life. The symptoms are usually mild and transient, especially in the case of selective serotonin reuptake inhibitors and venlafaxine. The occurrence of delirium as a result of the withdrawal of venlafaxine has not been reported previously. Even when antidepressants are being withdrawn with care, one should remain alert to the possible development of severe withdrawal symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132141

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  4 in total

1.  A case of interdose discontinuation symptoms with venlafaxine extended release.

Authors:  Joseph Petit; Randy A Sansone
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  Venlafaxine and serious withdrawal symptoms: warning to drivers.

Authors:  Daniel M Campagne
Journal:  MedGenMed       Date:  2005-07-06

3.  The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study.

Authors:  Gizat M Kassie; Elizabeth E Roughead; Tuan A Nguyen; Nicole L Pratt; Lisa M Kalisch Ellett
Journal:  Drug Saf       Date:  2021-11-08       Impact factor: 5.606

4.  Withdrawal Symptoms Following Discontinuation of Vortioxetine-Retrospective Chart Review.

Authors:  Marcin Siwek; Adrian Andrzej Chrobak; Aleksandra Gorostowicz; Anna Julia Krupa; Dominika Dudek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.